Japan’s probe Hayabusa 2 successfully lands on asteroid Ryugu

By Nikita Chaurasia  Date: 2019-02-22

Japan’s probe Hayabusa 2 successfully lands on asteroid Ryugu
  • It is being said that the asteroid contains relatively huge amounts of organic matter and water from about 4.6 billion years ago
  • The asteroid is around 3,000 feet in diameter and has been named after an undersea palace in a Japanese folktale

Japanese spacecraft Hayabusa 2 has successfully landed on an asteroid 170 million miles from the Earth as it attempts to collect samples and bring them back for researchers to study.

As per the officials of the Japan Aerospace Exploration Agency (JAXA), data from the spacecraft showed changes in direction and speed, suggesting it had landed on the asteroid, named Ryugu, and was blasting back to its orbiting position.

Reportedly, a live webcast of the control center showed numerous JAXA staff members nervously monitoring data ahead of the landing as they burst into applause after receiving a signal from the spacecraft that it had successfully landed.

Spokeswoman of JAXA, Chisato Ikuta was reportedly quoted saying that the agency confirmed the touchdown of the probe and the control center had received data showing that the spacecraft was working normally and is in good shape. Moreover, scientists were continuing to gather and analyze data received from the probe, Ikuta further added.

For the record, the asteroid is around 3,000 feet in diameter and has been named after an undersea palace in a Japanese folktale. It is being said that the asteroid contains relatively huge amounts of organic matter and water from about 4.6 billion years ago – the time when the solar system came into existence.

According to a report published by The Guardian, the probe aims to gather 10g of the dislodged debris with an equipment named the Sampler Horn which hangs from its underbelly. Hayabusa 2 was would fire a bullet toward the asteroid, in an attempt to stir up surface matter, which it would then carry back on Earth for analysis.

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

TCS, Infosys, Accenture workforce to receive free Covid-19 vaccination

TCS, Infosys, Accenture workforce to receive free Covid-19 vaccination

By Nikita Chaurasia

Information technology giants Infosys, Accenture India, and Tata Consultancy Services will reportedly cover Covid-19 vaccination costs for their employees and their family, who are eligible and opt to receive the jab. This news comes along the heels...

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

By Nikita Chaurasia

Motorola Solutions has announced to have been selected by Helsetjenestens Driftsorganisasjon for Nødnett HF (HDO HF) to offer the Norwegian Health Emergency Service with a new CRS (Command Central Control Room Solution). Confirming the news,&...

Nestle India exploring options to directly sell products to consumers

Nestle India exploring options to directly sell products to consumers

By Nikita Chaurasia

Nestle India Ltd. is reportedly exploring their options of trying their hands at direct selling since consumers are largely turning towards the internet to purchase products ranging from staples to medicines amidst the COVID-19 pandemic. While the n...

Razorpay: New funding en route, meteoric rise in market value expected

Razorpay: New funding en route, meteoric rise in market value expected

By Nikita Chaurasia

Indian startup Razorpay is reportedly in discussions with Singapore-based sovereign wealth fund GIC Pvt. Ltd. and other existing investors to raise around USD 200 million in a funding round that would allow the fintech company to double its valuation...

FDA to allow pharma companies modify COVID-19 shots amid variants surge

FDA to allow pharma companies modify COVID-19 shots amid variants surge

By Nikita Chaurasia

With the rising cases of Coronavirus variants, the United States Food & Drug Administration (FDA) has reportedly introduced guidelines for pharmaceutical companies to modify their COVID-19 vaccine doses in an effort to curb the spread of the dise...